Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Psychemedics Corporation (PMD) vs Precipio, Inc. (PRPO)

Psychemedics Corporation and Precipio, Inc. are both Diagnostics & Research companies. Precipio, Inc. is the larger, with a market value of $43.8M against $15.7M — 2.8× the size. Precipio, Inc. grew revenue faster over the last twelve months: 28.0% against −10.9%. Precipio, Inc. has the higher net margin (−4.47% vs −9.45%) and the higher return on invested capital (−7.63% vs −31.4%). Across the 20 metrics below, Precipio, Inc. leads on 11 and Psychemedics Corporation on 9.

Valuation

Metric PMD PRPO Diagnostics & Research median
P/E n/m n/m 33.95
P/S 0.80 1.55 4.87
P/B 3.05 2.86 3.12
Price to free cash flow 19.46 53.57 34.02
EV/EBITDA 77.29 135.71 25.20
EV/Sales 0.74 1.48 5.66
Earnings yield (11.99%) (2.71%) (1.75%)
Free cash flow yield 5.14% 1.87% (0.13%)

Profitability

Metric PMD PRPO Diagnostics & Research median
Gross margin 36.07% 44.11% 50.89%
Operating margin (9.62%) (5.68%) (8.57%)
Net margin (9.45%) (4.47%) (6.37%)
Free cash flow margin 4.02% 2.90% 0.00%
Return on equity (31.54%) (8.98%) (2.92%)
Return on assets (18.03%) (6.05%) (6.71%)
Return on invested capital (31.42%) (7.63%) 0.00%

Growth

Metric PMD PRPO Diagnostics & Research median
Revenue growth (TTM) (10.92%) 28.04% 7.69%
EPS growth (last fiscal year) 55.56% 92.15% —
Revenue growth, 5-year CAGR (12.18%) 31.60% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PMD PRPO Diagnostics & Research median
Debt to equity 0.01 0.07 0.11
Current ratio 1.82 1.77 2.02
Net debt to EBITDA (7.26) (3.30) 0.78

Dividend

Metric PMD PRPO Diagnostics & Research median
Dividend yield 4.79% — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric PMD PRPO Diagnostics & Research median
Market cap 15.70m 43.81m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack